leadf
logo-loader
viewSensyne Health PLC

Sensyne Health teams up with Oxford University for high-profile Covid trial

The study is funded by the COVID-19 Therapeutics Accelerator, set up by the Wellcome Trust and the Bill and Melinda Gates Foundation among others

Sensyne Health PLC -

Sensyne Health PLC (LON:SENS) has teamed up with Oxford University to provide the data analysis for a phase II clinical study of a blockbuster arthritis drug that is being re-purposed to tackle the potentially fatal symptoms of COVID-19.

Researchers are assessing whether anti-TNF treatment adalimumab, which is sold by AbbVie as Humira, can halt the progression of coronavirus – stopping it well before it causes respiratory failure.

The trial is funded by the COVID-19 Therapeutics Accelerator, set up by the Wellcome Trust, the Bill and Melinda Gates Foundation and Mastercard, with help from public and philanthropic donors.

Using Sensyne's software, symptom information, vital signs and daily activity information will be collected remotely from clinical study subjects in care homes.

This will be followed by a phase of exploratory data analysis using the firm’s machine learning algorithms.

The software is based on the CVm-Health application for tracking COVID-19 symptoms launched earlier this year.

Chief executive Lord Drayson said: "Sensyne is at the forefront of developing advanced remote monitoring software and clinical AI tools that enable clinical research to be undertaken during the new circumstances caused by the COVID-19 pandemic.

“We are delighted to be working with the University of Oxford on this important new trial of Adalimumab, pioneering new clinical research techniques in the community environment."

Quick facts: Sensyne Health PLC

Price: 150 GBX

AIM:SENS
Market: AIM
Market Cap: £192.86 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Sensyne Health PLC named herein, including the promotion by the Company of Sensyne Health PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Market Report: FTSE hot on heels of US rally and Rishi gets set to unveil...

FTSE 100 was buoyed early by the record highs seen on Wall Street overnight on the possibility Joe Biden might soon be declared President. London’s blue-chip index rose 35 to 6,461. Later today, Chancellor Rishi Sunak will unveil the government's spending plans for the coming...

2 days, 6 hours ago

2 min read